RadNet Inc. (RDNT)
NASDAQ: RDNT
· Real-Time Price · USD
55.76
-0.62 (-1.10%)
At close: May 09, 2025, 3:59 PM
55.73
-0.05%
After-hours: May 09, 2025, 07:27 PM EDT
RadNet Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Capitation Arrangements Revenue | 136.57M | 153.43M | 152.04M | 148.33M | 140.12M | 125.94M |
| Capitation Arrangements Revenue Growth | -10.99% | +0.91% | +2.50% | +5.86% | +11.26% | n/a |
| Commercial Insurance1 Revenue | 1.02B | 897.95M | 785.13M | 743.46M | 584.03M | 642.34M |
| Commercial Insurance1 Revenue Growth | +13.41% | +14.37% | +5.60% | +27.30% | -9.08% | n/a |
| Health Care, Management Service Revenue | 24.68M | 17.94M | 22.23M | 19.63M | 11.25M | 11.66M |
| Health Care, Management Service Revenue Growth | +37.58% | -19.33% | +13.27% | +74.44% | -3.48% | n/a |
| Health Care, Other Revenue | 46.72M | 20.11M | 19.43M | 13.85M | 23.3M | 24.55M |
| Health Care, Other Revenue Growth | +132.33% | +3.52% | +40.26% | -40.55% | -5.12% | n/a |
| Medicaid1 Revenue | 44.74M | 43.17M | 38.28M | 34.73M | 25.62M | 28.28M |
| Medicaid1 Revenue Growth | +3.62% | +12.79% | +10.22% | +35.57% | -9.42% | n/a |
| Medicare1 Revenue | 410.07M | 363.86M | 311.12M | 280.91M | 217.93M | 237.43M |
| Medicare1 Revenue Growth | +12.70% | +16.95% | +10.76% | +28.90% | -8.21% | n/a |
| Workers' Compensation/Personal Injury1 Revenue | 43.67M | 47.36M | 51.34M | 44.23M | 33.48M | 42.79M |
| Workers' Compensation/Personal Injury1 Revenue Growth | -7.81% | -7.74% | +16.06% | +32.13% | -21.77% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 41.14M | n/a | 29.9M | n/a | 59.83M | 29.78M | 30.05M | n/a | 123.06M | 31.42M | 31.21M | n/a | n/a | n/a | n/a | n/a | 108.2M | n/a | 26.55M | 26.9M | 106.5M | 26.85M | 26.94M | n/a | -1.09M | 82K | 279K | 726K | 255K | 1.19M | 177K | 203K | 349K | 2.19M | 173K | 167K | 448K | 167K | 94K | 36K |
| Selling, General, and Administrative Revenue Growth | n/a | -100.00% | n/a | -100.00% | +100.90% | -0.89% | n/a | -100.00% | +291.65% | +0.68% | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | -100.00% | -1.29% | -74.74% | +296.63% | -0.33% | n/a | -100.00% | -1425.61% | -70.61% | -61.57% | +184.71% | -78.50% | +570.06% | -12.81% | -41.83% | -84.05% | +1164.74% | +3.59% | -62.72% | +168.26% | +77.66% | +161.11% | n/a |
| Research and Development Revenue | n/a | n/a | 3.32M | 3.31M | 1.31M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | -100.00% | +0.06% | +153.44% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |